Author

Tatiana Harkovsky

Observed name: Tatiana Harkovski

Institutions: Ben-Gurion University of the Negev, Barzilai Medical Center

Observed institutions: Ben-Gurion University of the Negev, Barzilai Medical Center

OpenAlex ID: A5111571545

Biological insights from plasma proteomics of non-small cell lung cancer patients treated with immunotherapy

2024 · Jair Bar, Raya Leibowitz, et al. · Frontiers in Immunology · 15

Significance of lower uterine segment involvement in women with stage I endometrial adenocarcinoma.

2004 · Ofer Gemer, Leonid Uriev, et al. · PubMed · 9

Abstract 1208: Plasma proteomics-based models for predicting therapeutic benefit and immune-related adverse events in non-small cell lung cancer patients treated with immunotherapy

2024 · Michal Harel, Petros Christopoulos, et al. · Cancer Research · 2

Personalized approach for response prediction and treatment management for non-small cell lung cancer patients based on a liquid biopsy.

2022 · Yuval Shaked, Michal Harel, et al. · Journal of Clinical Oncology · 2

1229 Pre-treatment plasma proteomics-based predictive biomarkers for immune related adverse events in non-small cell lung cancer

2023 · Jarushka Naidoo, Niels Reinmuth, et al. · Regular and Young Investigator Award Abstracts

Is Neutrophil-to-Lymphocyte Ratio a Prediction Marker for Success of Immunotherapy? Preliminary Results

2018 · Noam Asna, Ornit Cohen, et al. · Open Journal of Immunology

Works count: 6

Citation count: 28

H-index: 2

I10-index: 1